Literature DB >> 9840586

Epidemiology of endemic Oropouche virus transmission in upper Amazonian Peru.

K J Baisley1, D M Watts, L E Munstermann, M L Wilson.   

Abstract

A cross-sectional serosurvey of a rural community near Iquitos, Peru was conducted to determine Oropouche (ORO) virus antibody prevalence and risk factors for human infection. Venous blood samples, and demographic, social, and risk factor data were obtained from people age five years of age and older who lived in the village of Santa Clara on the Nanay River, a tributary of the Amazon River. Sera were tested for ORO viral antibody by an ELISA. The specificity of viral antibody reactivity was determined by a standard plaque-reduction neutralization test. Interview data were analyzed by univariate and multiple logistic regression to determine which variables were statistically associated with previous ORO viral infection, as indicated by the presence of IgG antibody. Final models were evaluated based on log-likelihood and Wald chi-square. Clustering of seropositive residents within houses was analyzed by the method of Walter. Among 1,227 persons sampled, 33.7% (n=414) were positive for ORO viral IgG antibody. Overall, antibody prevalence was similar for males (33.9%) and females (33.6%), and increased significantly with age for both sexes to include more than half of persons more than 25 years of age. The length of residence in the village was positively associated with serologic status; persons who had moved to the village within the past 15 years were less likely to be seropositive than life-long residents of the same age. Antibody prevalence among immigrants who had lived in Santa Clara more than 15 years was similar to that in life-long residents. The activity most predictive of previous ORO viral infection was travel to forest communities and travel to Iquitos. No evidence of spatial heterogeneity in ORO virus antibody distribution was observed. Results suggested that endemic transmission of ORO virus in this region has been ongoing during many decades, and that people are at considerable risk of infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9840586     DOI: 10.4269/ajtmh.1998.59.710

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  13 in total

1.  Generation of Recombinant Oropouche Viruses Lacking the Nonstructural Protein NSm or NSs.

Authors:  Natasha L Tilston-Lunel; Gustavo Olszanski Acrani; Richard E Randall; Richard M Elliott
Journal:  J Virol       Date:  2015-12-23       Impact factor: 5.103

2.  Oropouche virus infection and pathogenesis are restricted by MAVS, IRF-3, IRF-7, and type I interferon signaling pathways in nonmyeloid cells.

Authors:  Jose Luiz Proenca-Modena; Renata Sesti-Costa; Amelia K Pinto; Justin M Richner; Helen M Lazear; Tiffany Lucas; Jennifer L Hyde; Michael S Diamond
Journal:  J Virol       Date:  2015-02-25       Impact factor: 5.103

3.  Iquitos virus: a novel reassortant Orthobunyavirus associated with human illness in Peru.

Authors:  Patricia V Aguilar; Alan D Barrett; Mohammad F Saeed; Douglas M Watts; Kevin Russell; Carolina Guevara; Julia S Ampuero; Luis Suarez; Manuel Cespedes; Joel M Montgomery; Eric S Halsey; Tadeusz J Kochel
Journal:  PLoS Negl Trop Dis       Date:  2011-09-20

4.  Genetic analysis of members of the species Oropouche virus and identification of a novel M segment sequence.

Authors:  Natasha L Tilston-Lunel; Joseph Hughes; Gustavo Olszanski Acrani; Daisy E A da Silva; Raimunda S S Azevedo; Sueli G Rodrigues; Pedro F C Vasconcelos; Marcio R T Nunes; Richard M Elliott
Journal:  J Gen Virol       Date:  2015-03-03       Impact factor: 3.891

5.  Emerging and reemerging arboviruses: A new threat in Eastern Peru.

Authors:  Carlos Alva-Urcia; Miguel Angel Aguilar-Luis; Carlos Palomares-Reyes; Wilmer Silva-Caso; Luis Suarez-Ognio; Pablo Weilg; Carlos Manrique; Fernando Vasquez-Achaya; Luis J Del Valle; Juana Del Valle-Mendoza
Journal:  PLoS One       Date:  2017-11-14       Impact factor: 3.240

Review 6.  Oropouche Virus: Clinical, Epidemiological, and Molecular Aspects of a Neglected Orthobunyavirus.

Authors:  Jorge Fernando Travassos da Rosa; William Marciel de Souza; Francisco de Paula Pinheiro; Mário Luiz Figueiredo; Jedson Ferreira Cardoso; Gustavo Olszanski Acrani; Márcio Roberto Teixeira Nunes
Journal:  Am J Trop Med Hyg       Date:  2017-02-06       Impact factor: 2.345

7.  MicroRNA and cellular targets profiling reveal miR-217 and miR-576-3p as proviral factors during Oropouche infection.

Authors:  Victor Emmanuel Viana Geddes; Anibal Silva de Oliveira; Amilcar Tanuri; Eurico Arruda; Marcelo Ribeiro-Alves; Renato Santana Aguiar
Journal:  PLoS Negl Trop Dis       Date:  2018-05-29

8.  Molecular detection and clinical characteristics of Bartonella bacilliformis, Leptospira spp., and Rickettsia spp. in the Southeastern Peruvian Amazon basin.

Authors:  Fiorella Ricapa-Antay; Katia Diaz-Melon; Wilmer Silva-Caso; Luis J Del Valle; Miguel Angel Aguilar-Luis; Fernando Vasquez-Achaya; Carlos Palomares-Reyes; Pablo Weilg; Dongmei Li; Carlos Manrique; Juana Del Valle-Mendoza
Journal:  BMC Infect Dis       Date:  2018-12-04       Impact factor: 3.090

9.  Infection, Dissemination, and Transmission Potential of North American Culex quinquefasciatus, Culex tarsalis, and Culicoides sonorensis for Oropouche Virus.

Authors:  Bethany L McGregor; C Roxanne Connelly; Joan L Kenney
Journal:  Viruses       Date:  2021-02-02       Impact factor: 5.048

Review 10.  Oropouche Fever: A Review.

Authors:  Hercules Sakkas; Petros Bozidis; Ashley Franks; Chrissanthy Papadopoulou
Journal:  Viruses       Date:  2018-04-04       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.